Hypophosphatasia Parent Diagnostic Odyssey Navigator
Kill Reason
Alexion already funds patient-finding tools because each identified HPP patient yields $200K+ treatment revenue (Strensiq); Soft Bones owns its own free patient registry — the distribution community is simultaneously the competing service provider; Veeva/IQVIA absorb the pharma-facing pivot.
Risk Analysis
Risk analysis available for latest engine ideas.
What do you think?
Related ideas you can explore free:
killed: Open-source middleware (HAMi) already provides heterogeneous AI computing virtualization for free. Proprietary play is squeezed between free open-source and vertically integrated hardware vendor ecosystem.
killed: 5+ funded competitors including Cast AI ($1B valuation), OneChronos (backed by Nobel laureate), Akash Network (decentralized, 80% cheaper), Argentum AI (blockchain-settled). Market is claimed with massive capital.
killed: Template epidemic (G003) + industry-pain-form death pattern (G005) fire simultaneously. 13+ existing compliance tools. A prompt could do 80% of this.